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Introduction

Underlying Pathophysiology
•

According to the Parkinson’s Disease (PD) Foundation, PD is a
progressive neurodegenerative disorder that affects
predominately dopamine-producing neurons in an area of the
brain called the substantia nigra (“Understanding parkinson’s,”
2019). This impairment of neurons causes individuals with PD to
have low levels or completely lack the neurotransmitter
dopamine in the brain (“Understanding parkinson’s,” 2019).
Dopamine plays a critical role in regulating motor function and
movements therefore, lack of dopamine will cause diminished
coordination and difficulty managing many motor skills
(“Understanding parkinson’s,” 2019). Bradykinesia (slowness of
movements), tremor at rest, and muscular rigidity are defined as
the cardinal triad symptoms seen in PD related to the lack of
dopamine in the brain (“Understanding parkinson’s,” 2019).
Dopamine also plays a critical role in cognition and controls
things like memory and judgment, hence the reason why some
individuals with PD may suffer cognitive impairment later in the
disease progression (“Understanding parkinson’s,” 2019). PD is a
complex, multi-faceted disease (Gopalakrishna & Alexander,
2015). The etiology remains somewhat unclear, but research
shows that genetic and environmental factors may play a role in
the onset of the disease (Capriotti & Terzakis, 2016). There is no
definitive diagnosis or cure and treatment options must be
tailored to the individual (Gopalakrishna & Alexander, 2015).
“Modern therapies and continuous research aim to evaluate the
pathophysiology of PD and manage symptoms so that patients
with the disease are living longer with increased quality of life
(Gopalakrishna & Alexander, 2015, 325).”

•
•

•

•

•

Agrawal, A. (2018, August 11). Typical appearance of
Parkinson's disease. Retrieved from
https://www.a4clinics.com/single-post/2018/08/12/5Things-to-Know-About-Parkinson’s-Disease

Case Process
A 62-year old Caucasian female presents for a routine annual visit. A full
history and physical is taken and below were the findings:
History: Elevated Cholesterol levels, Osteoporosis,
Chief Complaint: Patient reports that she has had a bilateral upper
extremity fine tremor for awhile, she reports stiffness in the morning,
she also states her right arm no longer swings normally like her left arm
does, her husband pointed this out to her while taking the dog on their
morning walks. Otherwise, she feels healthy.
After a full assessment is completed and further discussion with the
patient, the APRN refers her to a neurologist for further evaluation to
assist with possible diagnosis of Parkinson’s disease.
Diagnosis: No definitive tests are currently available to confirm a
diagnosis of Parkinson's disease (DeMaagd & Philip, 2015). Therefore, a
clinical diagnosis requires a full patient history, assessment of
symptoms, and rule out of any other alternative diagnoses (DeMaagd &
Philip, 2015). PD can be clinically diagnosed by the presence of two or
more of the cardinal motor symptoms including: rigidity (stiffness),
bradykinesia (slowness of movement), or resting tremor (Cotterell,
2018). There are no remarkable findings on MRI or CT studies typically
for PD patients, and genetic markers are still being investigated to help
with the diagnosis of PD (Capriotti & Terzakis, 2016).
Treatment: Currently, there is no cure for PD so the goal of treatment is
providing symptom management and maintaining or enhancing quality
of life (Capriotti & Terzakis, 2016). Levodopa is the gold standard
pharmacologic treatment for PD patients (Gopalakrishna & Alexander,
2015). Deep brain stimulation is a procedure that can be beneficial for
PD patients who have poorly controlled symptoms through medical
management (Capriotti & Terzakis, 2016).

While there have not been any concrete causes established, evidence and research suggest that
genetic and environmental factors contribute to the development as well as the progression of
PD (Gopalakrishna & Alexander, 2015).
A few of the gene mutations which research has identified to be associated with PD include:
Alpha-synuclein gene (SNCA), Glucocerebrosidase gene (GBA), and Leucine-rich repeat kinase 2
(LRRK2) gene loci (DeMaagd & Philip, 2015).
Environmental risk factors which research has identified to be associated with the development
and progression of PD include: Elevated cholesterol, environmental toxins (ie: pesticides), head
trauma, elevated body mass index (BMI), oxidative stress and the formation of free radicals from
exposure to numerous carcinogens (DeMaagd & Philip, 2015).
The hallmark pathophysiologic processes for PD are the loss of dopaminergic neurons of the
substantia nigra in the midbrain which are critical for smooth and fluid motor movements and
the formation or presence of Lewy bodies which contribute to the cognitive impairments
occasionally seen as the disease progresses into later stages (Gopalakrishna & Alexander, 2015).
Loss of dopaminergic neurons due to Nigrostiatal dopaminergic neurodegeneration in the basal
ganglia leads to an imbalance between excitation and inhibition pathways in the brain resulting
in the overall decrease in motor function for PD patients (Gopalakrishna & Alexander, 2015). The
presence of the nonmotor symptoms of PD supports the involvement of other neurotransmitters
of the glutamatergic, cholinergic, serotonergic, and adrenergic systems (DeMaagd & Philip,
2015).
There is still much to be discovered regarding the presence of Lewy bodies in PD patients. Some
research shows that the amount of Lewy bodies found in the Substantia nigra of PD patients with
dementia is significantly higher than PD patients without dementia. Other research suggests a
stronger association between cognitive impairment of PD with Lewy body distribution, rather
than the amount, within the cerebral cortex (DeMaagd & Philip, 2015).

Signs and Symptoms
The signs and symptoms of PD can vary based on
the individual and the progression of the disease and
can be classified as motor symptoms or nonmotor
symptoms. The classic symptoms are listed below.
Motor Signs and Symptoms:
Bradykinesia (slowness of movement)
Rigidity
Tremor at rest
Postural instability
Shuffling gait
Stooped posture
Dyskinesia (uncontrolled, involuntary muscle
movement)
•
Micrographia (small handwriting)
•
Reduced arm swinging
Nonmotor Signs and Symptoms:
•
Staring appearance/Masked facial expression
•
Flat affect
•
Depression/anxiety
•
Sleep disruption
•
Fatigue
•
Autonomic dysfunction including: inappropriate
diaphoresis, orthostatic hypotension, gastric
retention, constipation, and urinary retention
•
Cognitive impairment
•
Diminished speech volumes
•
Unexplained sensory disturbances (pain,
impaired smell, and vision) (Capriotti & Terzakis,
2016).
•
•
•
•
•
•
•

Nursing Implications
APRN’s must focus their care on maintaining/enhancing the patient’s quality
of life and independence by tailoring care and treating the symptomatic
motor and nonmotor symptoms of the disease (Biercewicz et al., 2016).
• Education on the medications prescribed and the importance of taking
medications on time as patients can go from “on” to “off” states quickly
(Capriotti & Terzakis, 2016).
• Help provide the patient with Physical Therapy or Occupational Therapy as a
resource to help them maintain their ability to perform ADL’s and reduce the
patient’s risks of falls (Biercewicz et al., 2016).
• Educate the patient on the benefits that physical exercise can have. Research
has begun to show that larger amounts of moderate-vigorous exercise may slow
the progression of PD, potentially protect the brain from further cognitive
impairment in later stages of the disease, and improve muscle strength and
walking speed for those struggling with the typical motor symptoms of PD
(Paillard, Rolland, & de Souto Barreto, 2015).
•Dysphagia and constipation are two common symptoms PD patients may
experience related to autonomic dysfunction or as a side effect of medications.
The APRN could help encourage the patient to speak with a speech therapist
and/or nutritionist to help combat these symptoms/side effects (Capriotti &
Terzakis, 2016).
• APRN’s can utilize the Parkinson
Neuropsychometric Dementia
Assessment or The Folstein Mini-Mental
Status Examination to evaluate cognitive
impairment for PD patient’s (Capriotti &
Terzakis, 2016).
• Encourage the patient to discuss their
experiences of living with PD with a
psychiatrist to maintain or improve
their mental/ emotional state
(Biercewicz et al., 2016).
• If symptoms are not being managed
well medically, the APRN could educate
the patient about the option of the
surgical intervention called Deep Brain
Delay the disease. (2017). Retrieved from
Stimulation (Capriotti & Terzakis, 2016).
http://www.delaythedisease.com/

Conclusions

Parkinson's disease. (2018, November 26). Retrieved from
https://labiotech.eu/features/immunotherapy-parkinsons-disease/

Significance of Pathophysiology
• Dopamine plays a critical role in regulating motor functions and movements, therefore lack of
dopamine will cause diminished coordination and difficulty managing many motor skills
("Understanding parkinson's," 2019).
• Dopamine also plays a critical role in cognition and controls things like memory and judgment, hence
the reason why some individuals with PD may suffer from cognitive impairment later in the disease
progression ("Understanding parkinson's," 2019).
• By having knowledge about the possible genetic and environmental factors associated with PD and
its pathophysiology, health care providers can educate patients on potential protective factors
including cholesterol levels and exercise (“Understanding parkinson’s,” 20119).
• By understanding the pathophysiology of PD, healthcare providers can prescribe appropriate
medications such as Levodopa or other dopaminergic medications to help manage or improve
symptoms by increasing the levels of dopamine in the brain(“Understanding parkinson’s,” 2019).
• Health care providers must understand the pathophysiology of the disease in order to tailor and
individualize care to help manage the patient's symptoms, maintain the patient's independence, and
enhance their overall quality of life.

Watching a parent navigate a life with PD is certainly one of the reasons this
topic was chosen. By understanding the pathophysiology of the disease,
learning what to expect as the disease progresses, and becoming
knowledgeable about treatment options as well as resources that are available
to provide the best quality of life possible will make the journey through PD a
little more bearable. Also, research and numbers show that more patients are
being diagnosed with neurodegenerative diseases like PD (Valera & Masliah,
2016). More than 10 million people worldwide are living with PD, and
approximately 60,000 Americans are diagnosed with PD each year
(“Understanding parkinson’s,” 2019). The World Health Organization (WHO)
predicts that by 2040, as the population continues to get older,
neurodegenerative diseases will become the second leading overall cause of
death following cardiovascular disease (Valera & Masliah, 2016). Advanced
Practice Nurses (APRN’s) in all settings will likely encounter patients with PD
and will have a role in clinical monitoring, identifying when problems arise, and
providing support and resources to their patients with PD as well as to their
family (Cotterell, 2018). PD can cause significant physical, psychological, and
social effects for patients (Cotterell, 2018). By understanding the disease and all
the effects, APRN’s will have the knowledge and resources necessary to provide
quality care to their patients (Cotterell, 2018). The role of the APRN is critical as
they work alongside Doctors, Pharmacists, Physical Therapy, Occupational
Therapy and Nutritionists (Gopalakrishna & Alexander, 2015). By learning and
understanding the pathophysiology of PD and its disease process, APRN’s have
the opportunity to help tailor care, minimize symptoms, improve motor
function, maximize patient outcomes, and provide increased quality of life for
their PD patients and families (Gopalakrishna & Alexander, 2015).
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